Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

US Press Releases


NASDAQ |  NYSE |  OTC
5/23/2024
Order by:

Reset Filters
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
5:00:00 PM
05/23/2024

Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
5:00:00 PM
05/23/2024

IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting
5:00:00 PM
05/23/2024

Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
5:00:00 PM
05/23/2024

Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
5:00:00 PM
05/23/2024

NVIDIA Announces Upcoming Event for Financial Community
5:00:00 PM
05/23/2024

MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBINATION AGREEMENT
5:00:00 PM
05/23/2024

Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
5:00:00 PM
05/23/2024

Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting
5:00:00 PM
05/23/2024

Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
5:00:00 PM
05/23/2024

Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
5:00:00 PM
05/23/2024